Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
A commentary on glial cell line-derived neurotrophic factor (GDNF): From a glial secreted molecule to gene therapy
Martha C. Bohn
*
*
Corresponding author for this work
Pediatrics
Research output
:
Contribution to journal
›
Article
›
peer-review
50
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A commentary on glial cell line-derived neurotrophic factor (GDNF): From a glial secreted molecule to gene therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Amyotrophic Lateral Sclerosis
9%
Biosynthesized
9%
Bona Fide
9%
Class-specific
9%
Effective Therapy
9%
Gene Therapy
100%
Glia
18%
Glial Cell Line-derived Neurotrophic Factor
100%
Mediated Transfer
9%
Neurodegeneration
9%
Neurotrophic Factors
18%
Parkinson's Disease Model
9%
Rat Model of Parkinson's Disease
9%
Secreted Molecules
100%
Slowly Progressive
9%
Therapeutic Agents
9%
Therapy Approaches
9%
Viral Vectors
9%
Neuroscience
Amyotrophic Lateral Sclerosis
9%
Glia
18%
Glial Cell Line-Derived Neurotrophic Factor
100%
Neurodegeneration
9%
Neurotrophic Factor
18%
Parkinson's Disease
18%
Virus Vector
9%